M Conte Selected Research

Cytotoxins (Cytolysins)

11/2010

Phenotypic characterization and putative virulence factors of human, animal and environmental isolates of Plesiomonas shigelloides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Conte Research Topics

Disease

3	Neoplasms (Cancer) 04/2013 - 12/2002
3	Scrapie 04/2007 - 02/2004
2	Asthma (Bronchial Asthma) 01/2022 - 10/2013
2	Breast Neoplasms (Breast Cancer) 11/2006 - 05/2000
2	Graves Disease (Basedow Disease) 06/2004 - 12/2000
2	Carcinoma (Carcinomatosis) 12/2002 - 05/2000
1	Rhinitis 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Perennial Allergic Rhinitis 01/2022
1	Down Syndrome (Down's Syndrome) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Teratoma (Teratoid Tumor) 11/2017
1	Dysgerminoma 11/2017
1	Laryngeal Neoplasms (Laryngeal Cancer) 10/2016
1	Squamous Cell Carcinoma of Head and Neck 10/2016
1	Muscular Atrophy (Muscle Atrophy) 08/2015
1	Sarcopenia 08/2015
1	Inflammation (Inflammations) 08/2015
1	Infections 01/2015
1	Aspergillosis 10/2014
1	Necrosis 04/2013
1	Intestinal Diseases (Diseases, Intestinal) 11/2010
1	Leukemia 02/2009
1	Cryptococcal Meningitis 02/2009
1	Autoimmune Hypophysitis 08/2008
1	Hyperprolactinemia 08/2008
1	Insulin Resistance 09/2007
1	Weight Gain 09/2007
1	Weight Loss (Weight Reduction) 09/2007
1	Dyslipidemias (Dyslipidemia) 09/2007
1	Cardiotoxicity 11/2006
1	Residual Neoplasm 11/2006

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 08/2008 - 06/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 02/2001
1	Dermatophagoides pteronyssinus antigen p 5IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 2IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 1IBA 01/2022
1	Dermatophagoides farinae antigen f 2IBA 01/2022
1	Dermatophagoides farinae antigen f 1IBA 01/2022
1	Pyridinolcarbamate (P23)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	P 11 (P-11)IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 7IBA 01/2022
1	AllergensIBA 01/2022
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Tumor Suppressor Protein p53IBA 08/2015
1	AgrinIBA 08/2015
1	galactomannanIBA 10/2014
1	AntigensIBA 10/2014
1	LeukotrienesIBA 10/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2013
1	CaspasesIBA 04/2013
1	RNA (Ribonucleic Acid)IBA 04/2013
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2013
1	genistinIBA 04/2013
1	Methanol (Carbinol)IBA 04/2013
1	Hemolysin Proteins (Hemolysins)IBA 11/2010
1	Cytotoxins (Cytolysins)IBA 11/2010
1	Voriconazole (Vfend)FDA LinkGeneric 02/2009
1	Cabergoline FDA LinkGeneric 08/2008
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2008
1	ThiazolidinedionesIBA 09/2007
1	Indapamide FDA LinkGeneric 09/2007
1	DiureticsIBA 09/2007
1	LipidsIBA 09/2007
1	Metformin (Glucophage)FDA LinkGeneric 09/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2007
1	Antihypertensive Agents (Antihypertensives)IBA 09/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2007
1	AldosteroneIBA 09/2007
1	SodiumIBA 09/2007
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2007
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 09/2007
1	Acarbose FDA LinkGeneric 09/2007
1	Angiotensin Receptor AntagonistsIBA 09/2007
1	Fibric Acids (Fibrates)IBA 09/2007
1	Methionine (L-Methionine)FDA Link 04/2007
1	Isoleucine (L-Isoleucine)FDA Link 04/2007
1	Liposomes (Liposome)IBA 11/2006
1	AnthracyclinesIBA 11/2006
1	Bevacizumab (Avastin)FDA Link 11/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2006
1	Monoclonal AntibodiesIBA 11/2006
1	Capecitabine (Xeloda)FDA Link 11/2006

Therapy/Procedure

6	Therapeutics 01/2015 - 05/2000
4	Drug Therapy (Chemotherapy) 11/2017 - 05/2000
2	Knee Replacement Arthroplasty (Total Knee Replacement) 08/2015 - 08/2015
2	Parathyroidectomy 04/2001 - 12/2000
1	Lasers (Laser) 10/2016
1	Laryngectomy 10/2016
1	Aftercare (After-Treatment) 01/2015
1	Debridement 01/2015
1	Central Venous Catheters 08/2010
1	Parenteral Nutrition 08/2010
1	Bariatric Surgery 09/2007
1	Sympathectomy (Sympathectomies) 10/2006